Answers are grounded in this paper and cite their sources.
BACKGROUND: Since 1930 it has been accepted that intravenous injection of iodinated contrast agent as part of contrast-enhanced computed tomography (CE-CT) imaging can induce a contrast-associated acute kidney injury (CA-AKI). For the last 10 years, studies have investigated this iatrogenia. However, those works didn't concern patient hospitalised after emergency department (ED) visit. This study assessed the CA-AKI incidence and risk factors in patients hospitalised after a CE-CT in ED. MATERIALS AND METHODS: This was a monocentric retrospective study, conducted in a University Hospital ED (Beaujon Hospital) between 2019 and 2022. Patients over 16 years old who received a CE-CT and two serum creatinine dosages, one pre-CT and one post-CT (2 to 7 days later), were included. Risk factors and protective factors of CA-AKI as well as population characteristics were analysed. RESULTS: After studying 5079 enhanced CT-scans, 1463 patients fulfilled the inclusion criteria. The incidence of CA-AKI was 4.1%. The associated risk factors were: hypertension (adjusted odds ratio (aOR) = 3.36, 95% confidence interval (CI) (1.76-6.43)), CKD grade 4-5 (aOR = 5.89, 95% CI (1.39-24.95)), waiting time before CT (aOR = 3.36, 95% CI (1.76-6.43)). Ongoing treatment by metformin was found to be a protective factor (aOR = 0.26, 95% CI (0.06-1.12)). CONCLUSION: Our findings suggest that only hypertension and stage 4-5 CKD significantly increase the risk of CA-AKI. Consequently, CT imaging should not be unnecessarily delayed when clinically justified, as prompt diagnosis could help limit morbidity and mortality. CLINICAL TRIAL NUMBER: The study was registered at ClinicalTrials.gov on 22 July 2025 (NCT07091656).
No takes yet. Share an insight, caveat, or question.
Lecomte et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: